Library Portal | UWC Portal | National ETDs | Global ETDs
    • Login
    Contact Us | Quick Submission Guide | About Us | FAQs | Login
    View Item 
    •   ETD Home
    • Faculty of Natural Science
    • School of Pharmacy
    • Magister Pharmaceuticae - MPharm
    • View Item
    •   ETD Home
    • Faculty of Natural Science
    • School of Pharmacy
    • Magister Pharmaceuticae - MPharm
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Development of a model to predict the cost of treatment of breast cancer with chemotherapy at Groote Schuur hospital

    Thumbnail
    View/Open
    Guzha nsc.pdf (5.322Mb)
    Date
    2017
    Author
    Guzha, Nyasha Talent
    Metadata
    Show full item record
    Abstract
    In South Africa, breast cancer dominates other forms of cancer affecting women in both prevalence and mortality rates according to the National Cancer Registry. The incidence and cost of breast cancer have been on the rise particularly in developing countries. To date, there has been no study on the financial burden of breast cancer in the South African public sector. The aim of this study was to develop a method of costing breast cancer treatment with chemotherapy at Groote Schuur hospital (GSH), a government hospital. The objective was to determine the direct medical costs associated with breast cancer treatment and management of chemotherapy adverse events.
    URI
    http://hdl.handle.net/11394/5925
    Collections
    • Magister Pharmaceuticae - MPharm [86]

    DSpace 5.5 | Ubuntu 14.04 | Copyright © University of the Western Cape
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace 5.5 | Ubuntu 14.04 | Copyright © University of the Western Cape
    Contact Us | Send Feedback
    Theme by 
    @mire NV